- Home
- OVID vs LSTA Comparison
OVID vs LSTA Comparison
Compare OVID & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OVID
- LSTA
- Stock Information
- Founded
- OVID 2014
- LSTA 1980
- Country
- OVID United States
- LSTA United States
- Employees
- OVID N/A
- LSTA N/A
- Industry
- OVID Biotechnology: Pharmaceutical Preparations
- LSTA Misc Health and Biotechnology Services
- Sector
- OVID Health Care
- LSTA Health Care
- Exchange
- OVID Nasdaq
- LSTA Nasdaq
- Market Cap
- OVID 20.6M
- LSTA 20.0M
- IPO Year
- OVID 2017
- LSTA N/A
- Fundamental
- Price
- OVID $0.31
- LSTA $2.48
- Analyst Decision
- OVID Strong Buy
- LSTA Strong Buy
- Analyst Count
- OVID 4
- LSTA 1
- Target Price
- OVID $3.13
- LSTA $15.00
- AVG Volume (30 Days)
- OVID 969.8K
- LSTA 9.0K
- Earning Date
- OVID 08-12-2025
- LSTA 08-11-2025
- Dividend Yield
- OVID N/A
- LSTA N/A
- EPS Growth
- OVID N/A
- LSTA N/A
- EPS
- OVID N/A
- LSTA N/A
- Revenue
- OVID $548,000.00
- LSTA $1,000,000.00
- Revenue This Year
- OVID N/A
- LSTA N/A
- Revenue Next Year
- OVID $5.32
- LSTA N/A
- P/E Ratio
- OVID N/A
- LSTA N/A
- Revenue Growth
- OVID 15.61
- LSTA N/A
- 52 Week Low
- OVID $0.24
- LSTA $1.87
- 52 Week High
- OVID $1.47
- LSTA $4.20
- Technical
- Relative Strength Index (RSI)
- OVID 52.32
- LSTA 48.41
- Support Level
- OVID $0.29
- LSTA $2.35
- Resistance Level
- OVID $0.32
- LSTA $2.71
- Average True Range (ATR)
- OVID 0.03
- LSTA 0.17
- MACD
- OVID 0.00
- LSTA -0.03
- Stochastic Oscillator
- OVID 50.50
- LSTA 28.89
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.